“A Double-Masked, Randomized Study to Investigate the Safety and Efficacy of Daclizumab to Treat the Ocular Complications Related to Behçet's Disease”, Ocul Immunol Inflamm, vol. 15, pp. 63-70, 2007.,
“Daclizumab therapy in Uveitis patients: Preliminary safety and activity data for establishing parameters for subcutaneous administration for long term therapy”, 2003.,
“Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration”, J Autoimmun, vol. 21, pp. 283-293, 2003.
“A masked randomized study to investigate the safety and efficacy of Daclizumab for treatment of Ocular Behcet’s Disease”, 2003.,
“A Study to investigate the Safety and Efficacy of Daclizumab to treat the ocular complications related to the Behcet’s disease”, 2003.,